← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #172 OF 1,000 MOST-CITED

Master manufacturing record - unique formulation

FDA cited this observation 135 times across 129 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods135
BY FISCAL YEAR
FY202422
FY202314
FY202214
FY20218
FY202010
FY201921
FY201830
FY201716

How FDA worded it — real examples

You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

Quantum Fulfillment and Support, LLC · Cedar Creek, Texas · Foods · 2024-07-26

You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

M2 Ingredients, Inc. - Park Center · Vista, California · Foods · 2024-07-26

You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

SUNYATA PRODUTOS ALTERNATIVOS LTDA · Atibaia · Foods · 2024-07-19

You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

NeuroScience Solutions, Inc. · Osceola, Wisconsin · Foods · 2024-07-01

You did not prepare and follow a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

NOW Health Group Inc. · Bloomingdale, Illinois · Foods · 2024-06-27

You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

I AM WELL HOLISTIC INC · Cleveland, Ohio · Foods · 2024-05-28

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →